XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital & Accumulated Other Comprehensive Loss
Retained Earnings
Adoption of current expected credit loss ("CECL")
Adoption of current expected credit loss ("CECL")
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2019   19,071,614        
Beginning balance at Dec. 31, 2019 $ 250,094 $ 2 $ 85,273 $ 164,819 $ (365) $ (365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (4,539)     (4,539)    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   1,918        
Issuance of restricted stock under the 2012 Equity Plan and other 19     19    
Purchase of common stock for tax withholding (shares)   (79,981)        
Purchase of common stock for tax withholding (903)   (903)      
Amortization of stock-based compensation 1,182   1,182      
Cash dividends declared (2,488)     (2,488)    
Cumulative translation adjustment (220)   (220)      
Ending balance (in shares) at Mar. 31, 2020   18,993,551        
Ending balance at Mar. 31, 2020 242,780 $ 2 85,332 157,446    
Beginning balance (in shares) at Dec. 31, 2019   19,071,614        
Beginning balance at Dec. 31, 2019 250,094 $ 2 85,273 164,819 $ (365) $ (365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 2,384          
Cumulative translation adjustment (55)          
Ending balance (in shares) at Sep. 30, 2020   19,052,011        
Ending balance at Sep. 30, 2020 248,022 $ 2 88,641 159,379    
Beginning balance (in shares) at Mar. 31, 2020   18,993,551        
Beginning balance at Mar. 31, 2020 242,780 $ 2 85,332 157,446    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 3,759     3,759    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   30,244        
Issuance of restricted stock under the 2012 Equity Plan and other 168   166 2    
Amortization of stock-based compensation 1,362   1,362      
Cash dividends declared (2,491)     (2,491)    
Cumulative translation adjustment 103   103      
Ending balance (in shares) at Jun. 30, 2020   19,023,795        
Ending balance at Jun. 30, 2020 245,681 $ 2 86,963 158,716    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 3,165     3,165    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   28,216        
Issuance of restricted stock under the 2012 Equity Plan and other (8)     (8)    
Amortization of stock-based compensation 1,616   1,616      
Cash dividends declared (2,494)     (2,494)    
Cumulative translation adjustment 62   62      
Ending balance (in shares) at Sep. 30, 2020   19,052,011        
Ending balance at Sep. 30, 2020 248,022 $ 2 88,641 159,379    
Beginning balance (in shares) at Dec. 31, 2020   19,384,192        
Beginning balance at Dec. 31, 2020 200,613 $ 2 90,328 110,283    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,297)     (2,297)    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   20,952        
Purchase of common stock for tax withholding (shares)   (132,281)        
Purchase of common stock for tax withholding (1,444)   (1,444)      
Amortization of stock-based compensation 2,239   2,239      
Cash dividends declared (2,553)     (2,553)    
Issuance of common stock in lieu of cash compensation (in shares)   50,741        
Cumulative translation adjustment 14   14      
Ending balance (in shares) at Mar. 31, 2021   19,323,604        
Ending balance at Mar. 31, 2021 196,572 $ 2 91,137 105,433    
Beginning balance (in shares) at Dec. 31, 2020   19,384,192        
Beginning balance at Dec. 31, 2020 200,613 $ 2 90,328 110,283    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (5,510)          
Cumulative translation adjustment (146)          
Ending balance at Sep. 30, 2021 191,614 $ 2 94,490 97,122    
Beginning balance (in shares) at Mar. 31, 2021   19,323,604        
Beginning balance at Mar. 31, 2021 196,572 $ 2 91,137 105,433    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (719)     (719)    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   39,010        
Issuance of restricted stock under the 2012 Equity Plan and other 132   132 0    
Purchase of common stock for tax withholding (shares)   (19,874)        
Purchase of common stock for tax withholding (212)   (212)      
Amortization of stock-based compensation 1,781   1,781      
Cash dividends declared (2,553)     (2,553)    
Issuance of common stock in lieu of cash compensation (in shares)   58,430        
Cumulative translation adjustment 3   3      
Ending balance (in shares) at Jun. 30, 2021   19,401,170        
Ending balance at Jun. 30, 2021 195,004 $ 2 92,841 102,161    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,494)     (2,494)    
Issuance of restricted stock under the 2012 equity plan and other (in shares)   26,772        
Purchase of common stock for tax withholding (shares)   (20,439)        
Purchase of common stock for tax withholding (204)   (204)      
Amortization of stock-based compensation 2,016   2,016      
Cash dividends declared (2,545)     (2,545)    
Issuance of common stock in lieu of cash compensation (in shares)   60,773        
Cumulative translation adjustment (163)   (163)      
Ending balance at Sep. 30, 2021 $ 191,614 $ 2 $ 94,490 $ 97,122